Melinta Therapeutics, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Melinta Therapeutics, Inc.
Quantité totale PI 51
Rang # Quantité totale PI 27 560
Note d'activité PI 0,4/5.0    1
Rang # Activité PI 958 378
Symbole boursier MLNT (nasdaq)
Capitalisation 6.875M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

29 1
3 2
15 0
1
 
Dernier brevet 2021 - Methods of treating bacterial in...
Premier brevet 2000 - Crystals of the large ribosomal ...
Dernière marque 2017 - VABOMERE
Première marque 2013 - ORBACTIV

Industrie (Classification de Nice)

Derniers inventions, produits et services

2019 Invention Synthesis of boronate salts and uses thereof. Disclosed herein are boronate intermediates in the ...
Invention Methods of treating bacterial infections with minocycline. Disclosed herein are methods of treat...
2018 Invention Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives....
Invention Methods of treating bacterial infections. Methods of treating or ameliorating a bacterial infect...
P/S Pharmaceutical preparations, namely, anti-infective preparations and substances for medical purpo...
Invention Triazole compounds and methods of making and using the same. The present invention provides triaz...
Invention Pharmaceutical compositions comprising cyclic boronic acid ester derivatives. Disclosed herein ar...
Invention Methods of treating bacterial infections. Methods of treating or ameliorating urinary tract infe...
2017 Invention Methods for treating infections. The present invention relates to methods for treating, preventi...
Invention Cyclic boronic acid ester derivatives and methods of making the same. Disclosed herein are antimi...
Invention Antimicrobials and methods of making and using same. The present disclosure relates generally to ...
Invention Oritavancin formulations. Disclosed herein are antibacterial pharmaceutical compositions comprisi...
2016 Invention Antimicrobial compounds and methods of making and using the same. The present disclosure relates ...
Invention Cyclic boronic acid ester derivatives and therapeutic uses thereof. Disclosed herein are antimicr...
2015 Invention Apparatus and continuous flow process for production of boronic acid derivatives. A process for a...
Invention Method for treating, preventing, or reducing the risk of skin infection. The present invention re...
Invention Methods for treating infections. The present invention relates to methods for treating, preventin...
Invention Antimicrobial compositions with effervescent agents. The present invention relates to pharmaceuti...
Invention Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof. Discl...
2014 Invention Ribosome structure and protein synthesis inhibitors. The invention provides methods for producin...
Invention Antimicrobial compounds and methods of making and using the same. Methods and compounds for treat...
Invention Antimicrobial compunds and methods of making and using the same. The present invention relates ge...
Invention Methods for treating bacterial infections using oritavancin and polymyxins. Methods of treating b...
Invention Methods for treating bacteremia and osteomyelitis using oritavancin. Methods of treating bacteri...
P/S Pharmaceutical preparations, namely, anti-infective preparations and substances
Invention Treatment and prevention of bacterial skin infections using oritavancin. Methods for the treatme...
Invention Methods of treating gonorrhea infections using quinolone antibiotics. The present disclosure rela...
Invention Methods of treating infections in overweight and obese patients using antibiotics. The present di...
Invention Tetracycline compositions. The present invention relates to compositions, pharmaceutical composit...
Invention Crystalline forms of d-glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridine-2-yl)-...
Invention Crystalline forms of d-glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3, 5-difluoropyridine-2-yl)...
2013 Invention Clostridium difficile by administration of oritavancin. C. difficile infection and disease in ani...
P/S Pharmaceutical preparations, namely, anti-infective preparations and substances
Invention Method of inhibiting clostridium difficile by administration of oritavancin. C. difficile infecti...
Invention Process for making quinolone compounds. The present invention relates to the field of synthesizin...
Invention Protein synthesis modulators. The invention provides a high resolution three-dimensional structu...
Invention Cyclic boronic acid ester derivatives and therapeutic uses thereof. Method of treating or amelior...
Invention Biaryl heterocyclic compounds and methods of making and using the same. The present invention re...
Invention Methods of treatment using single doses of oritavancin. Glycopeptide antibiotics, such as oritav...
2012 Invention Disk diffusion assay for oritavancin. The present invention is directed to a disk diffusion assay...
Invention Antimicrobial compounds and methods of making and using the same. The present invention relates g...
2011 Invention Pharmaceutical compositions. The present invention relates to pharmaceutical compositions useful...
2010 Invention Glycopeptide and lipoglycopeptide antibiotics with improved solubility. The invention relates to ...